Table 2.
Univariate regression analysis between VO2max and metabolic risk factors.
| P | F | T | |
|---|---|---|---|
| Age | .0062 | 7,64 | −2.976 |
| Tanner stage | .0018 | 10.043 | −3.169 |
| BMI | <.0001 | 83.809 | −9.55 |
| z score | <.0001 | 48.949 | −6.99 |
| Fat Free Mass kg | .0002 | 14.576 | −3.818 |
| Fat Free Mass % | <.0001 | 43.856 | 6.622 |
| Fat Mass kg | <.0001 | 92.285 | −9.761 |
| Fat Mass % | <.0001 | 56.838 | −7.539 |
| Systolic BP | .124 | ||
| Diastolic BP | .072 | ||
| Fasting Glucose | .220 | ||
| Fasting Insulin | <.0001 | −5.52 | |
| HOMA-IR | <.0001 | −4.98 | |
| Triglycerides | .010 | −2.59 | |
| HDL Cholesterol | .019 | 2.36 | |
| LDL Cholesterol | .509 | ||
| AST | .770 | ||
| ALT | .0007 | −3.421 | |
| Sedimentation rate | .0002 | 14.26 | −3.776 |
| Fibrinogen | .0005 | 8.012 | −2.831 |